Blue Cross Blue Shield of Massachusetts (BCBSMA) has announced a new community partner strategy that will focus on four key areas: healthy child development, education enrichment, healthy environments and family nutrition, and sustainable health care.
Blue Cross Blue Shield of Massachusetts (BCBSMA) has announced a new community partner strategy that will focus on four key areas: healthy child development, education enrichment, healthy environments and family nutrition, and sustainable health care. The strategy will direct charitable contributions, volunteer time, and board leadership support toward those four areas.
“After reviewing our community involvement and discussing it with company executives and employees on all levels, as well as a cross section of community leaders, we identified four focus areas that align with our company vision,” said Jeff Bellows in a press statement. Bellows is senior director of Community Relations at BCBSMA. “We will work collaboratively with our partners to improve the health and wellbeing of Massachusetts’ residents, the environment and health care system of the state.”
Last year, BCBSMA employees donated $7.5 million through community work and contributions to local charities, volunteered a total of 14,700 hours at different charitable organizations and assisted with 160 volunteer projects statewide, according to BCBSMA President and CEO Andrew Dreyfus.
BCBSMA is the largest private health plan in Massachusetts, providing coverage to nearly 3 million members.
Briana Contreras, an editor of Managed Healthcare Executive, spoke with Fred Turner, CEO of Curative, in this month’s episode about the challenges middle-class Americans face in dealing with medical debt, exploring the causes behind it and the impact on overall health.
Listen
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen